Clinical trial / 1990
Plasma beta-endorphin levels increased in the early phase of fasting but were lower in individuals who tolerated longer fasts.
Plasma beta-endorphin (beta-EP), serum cortisol, and nutritional markers were evaluated in 17 patients before, during, and after fasting. Participants were split a posteriori into group A (11 patients who tolerated 5-7 days of fasting) and group B (6 patients who tolerated 10 days). By the 5th day of fasting, beta-EP increased from 4.74 +/- 0.42 to 6.91 +/- 0.65 pmol/l in group A (p < 0.01) and from 3.60 +/- 0.48 to 5.14 +/- 0.22 pmol/l in group B (p < 0.05), remaining at 5.05 +/- 0.65 pmol/l on day 10 in group B. Group B exhibited lower beta-EP levels on day 5 than group A (p < 0.05), while cortisol changed similarly in both groups. Beta-EP showed no significant correlation with percentage of body weight lost or body mass index.
- Study type
- Interventional fasting study
- Who was studied
- 17 patients
- What was measured
- Plasma beta-endorphin, serum cortisol, and circulating nutritional markers
THE PAPER
Plasma beta-endorphin during fasting in man.
Komaki G, Tamai H, Sumioki H, Mori T, Kobayashi N, Mori K, Mori S, Nakagawa T. Horm Res, 1990.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.